Healthcare 3D Printing Market Size By Product, By Technology, By Application, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2023

Description

List of Tables

The global healthcare 3D printing market is poised to grow steadily through 2032 owing to the surging need for personalized implants. In addition, the rising number of advanced solutions in the medical and pharmacology sector is likely to boost the industry outlook.

The growing demand for 3D-printed implants is linked to time savings and reduced scope of error, allowing healthcare professionals to provide patients with tailored solutions. Additionally, there is a rising global need for surgical implants, especially dental implants, driving up the sales of 3D printing.

Healthcare 3D printing market players are engaged in industry tactics such as acquisitions, partnerships, and more allowing them to gain a competitive advantage in the marketplace. For instance, in January 2022, Materialise NV took over Link3D Inc, one of the top firms in the additive workflow as well as digital manufacturing systems. With cloud-based access to its integrated software platform, the acquisition aims to improve the firm's additive manufacturing (AM) capabilities in large-volume production.

The healthcare 3D printing market has been divided in terms of product, technology, application, and region.

Based on product, the laser-based segment recorded more than 18.5% market share in 2022. Laser printers have improved the speed of DNA printing process and made it more accessible, allowing for more efficient drug development. DNA laser printers produce more viable DNA than traditional methods, thereby fostering segmental growth through the forecast period.

With respect to technology, the fused deposition modeling (FDM) segment recorded more than $1 billion in revenue in 2022. Extensive technological applications in the healthcare industry, such as tissue engineering, implants, external wearables, and clinical gadgets, are attributed to the rising segmental growth. Additionally, the benefits and affordability of fused deposition modeling technology compared to other technologies is anticipated to contribute to the market growth through the end of the research timeframe.

In terms of application, the biosensors segment is set to attain high gains through 2032 credited to the widespread product applications in numerous fields of research and development.

From the regional front, the Middle East & Africa healthcare 3D printing market was valued at more than $175 million in 2022. The regional demand is projected to proliferate robustly by the end of the research years ascribed to the rising usage of advanced technology in research programs and technological improvement of the 3D printing technology in the medical industry.

The competitive landscape of healthcare 3D printing industry is highly consolidated. The companies partaking in the marketplace are Bio3D Technologies, Envision TEC, Renishaw, Aprecia Pharmaceuticals, regenHU, and Aspect Biosystems, amongst others.

Product Code: 1997

Chapter 1 Methodology

1.1 Methodology
1.2 Market definition
1.3 Forecast parameters
1.4 Data sources
- 1.4.1 Secondary
  - 1.4.1.1 Paid sources
  - 1.4.1.2 Unpaid sources
- 1.4.2 Primary

Chapter 2 Executive Summary

2.1 Healthcare 3D printing industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Technology trends
- 2.1.4 Application trends
- 2.1.5 Regional trends

Chapter 3 Healthcare 3D Printing Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Technological advancements
  - 3.3.1.2 Extended clinical applications
  - 3.3.1.3 Increasing demand for custom implants
  - 3.3.1.4 Increasing R&D investments from manufacturers and institutions
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Lack of skilled professionals
  - 3.3.2.2. High price associated with 3 D printing
3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By technology
- 3.4.3 By application
3.5 COVID-19 impact analysis
3.6 Porter's analysis
- 3.6.1 Industry rivalry
- 3.6.2 Buyer power
- 3.6.3 Supplier power
- 3.6.4 Threat of substitute
- 3.6.5 Threat of new entrants
3.7 PESTEL analysis
- 3.7.1 Political
- 3.7.2 Economical
- 3.7.3 Social
- 3.7.4 Technological
- 3.7.5 Environmental
- 3.7.6 Legal

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis
4.3 Strategic dashboard

Chapter 5 Healthcare 3D Printing Market, By Product

5.1 Key segment trends
5.2 Syringe based,
- 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Magnetic levitation
- 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Laser based
- 5.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Inkjet based
- 5.5.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Healthcare 3D Printing Market, By Technology

6.1 Key segment trends
6.2 Fused deposition modelling (FDM)
- 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Selective laser sintering (SLS)
- 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Stereolithography
- 6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Others
- 6.5.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Healthcare 3D Printing Market, By Application

7.1 Key segment trends
7.2 Biosensors
- 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Medical
- 7.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 7.3.2 Pharmaceuticals
  - 7.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 7.3.3 Prosthetics and implants
  - 7.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 7.3.4 Tissue and organ generation
  - 7.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Dental
- 7.4.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 8 Healthcare 3D Printing Market, By Region

8.1 Key regional trends
8.2 North America
- 8.2.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.2.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.2.3 Market size, by technology, 2018 - 2032 (USD Million)
- 8.2.4 Market size, by application, 2018 - 2032 (USD Million)
  - 8.2.4.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.2.5 U.S.
  - 8.2.5.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.2.5.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.2.5.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.2.5.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.2.6 Canada
  - 8.2.6.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.2.6.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.2.6.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.2.6.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.3 Europe
- 8.3.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.3.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.3.3 Market size, by technology, 2018 - 2032 (USD Million)
- 8.3.4 Market size, by application, 2018 - 2032 (USD Million)
  - 8.3.4.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.3.5 Germany
  - 8.3.5.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.3.5.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.3.5.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.3.5.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.3.6 UK
  - 8.3.6.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.3.6.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.3.6.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.3.6.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.3.7 France
  - 8.3.7.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.3.7.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.3.7.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.3.7.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.3.8 Italy
  - 8.3.8.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.3.8.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.3.8.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.3.8.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.3.9 Spain
  - 8.3.9.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.3.9.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.3.9.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.3.9.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.3.10 Russia
  - 8.3.10.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.3.10.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.3.10.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.3.10.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.4 Asia Pacific
- 8.4.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.4.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.4.3 Market size, by technology, 2018 - 2032 (USD Million)
- 8.4.4 Market size, by application, 2018 - 2032 (USD Million)
  - 8.4.4.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.4.5 Japan
  - 8.4.5.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.4.5.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.4.5.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.4.5.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.4.6 China
  - 8.4.6.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.4.6.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.4.6.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.4.6.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.4.7 India
  - 8.4.7.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.4.7.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.4.7.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.4.7.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.4.8 Australia
  - 8.4.8.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.4.8.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.4.8.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.4.8.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.4.9 South Korea
  - 8.4.9.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.4.9.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.4.9.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.4.9.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.5 Latin America
- 8.5.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.5.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.5.3 Market size, by technology, 2018 - 2032 (USD Million)
- 8.5.4 Market size, by application, 2018 - 2032 (USD Million)
  - 8.5.4.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.5.5 Brazil
  - 8.5.5.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.5.5.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.5.5.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.5.5.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.5.6 Mexico
  - 8.5.6.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.5.6.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.5.6.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.5.6.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.5.7 Argentina
  - 8.5.7.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.5.7.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.5.7.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.5.7.3.1 Market size, by medical, 2018 - 2032 (USD Million)
8.6 MEA
- 8.6.1 Market size, by country, 2018 - 2032 (USD Million)
- 8.6.2 Market size, by product, 2018 - 2032 (USD Million)
- 8.6.3 Market size, by technology, 2018 - 2032 (USD Million)
- 8.6.4 Market size, by application, 2018 - 2032 (USD Million)
  - 8.6.4.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.6.5 South Africa
  - 8.6.5.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.6.5.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.6.5.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.6.5.3.1 Market size, by medical, 2018 - 2032 (USD Million)
- 8.6.6 Saudi Arabia
  - 8.6.6.1 Market size, by product, 2018 - 2032 (USD Million)
  - 8.6.6.2 Market size, by technology, 2018 - 2032 (USD Million)
  - 8.6.6.3 Market size, by application, 2018 - 2032 (USD Million)
    - 8.6.6.3.1 Market size, by medical, 2018 - 2032 (USD Million)

Chapter 9 Company Profiles

9.1 Aprecia Pharmaceuticals
- 9.1.1 Business overview
- 9.1.2 Financial data
- 9.1.3 Product landscape
- 9.1.4 Strategic outlook
- 9.1.5 SWOT analysis
9.2 Aspect Biosystems
- 9.2.1 Business overview
- 9.2.2 Financial data
- 9.2.3 Product landscape
- 9.2.4 Strategic outlook
- 9.2.5 SWOT analysis
9.3 Bio 3D Technologies
- 9.3.1 Business overview
- 9.3.2 Financial data
- 9.3.3 Product landscape
- 9.3.4 Strategic outlook
- 9.3.5 SWOT analysis
9.4 BioBots
- 9.4.1 Business overview
- 9.4.2 Financial data
- 9.4.3 Product landscape
- 9.4.4 Strategic outlook
- 9.4.5 SWOT analysis
9.5 Cyfuse Biomedical
- 9.5.1 Business overview
- 9.5.2 Financial data
- 9.5.3 Product landscape
- 9.5.4 Strategic outlook
- 9.5.5 SWOT analysis
9.6 Digilab
- 9.6.1 Business overview
- 9.6.2 Financial data
- 9.6.3 Product landscape
- 9.6.4 Strategic outlook
- 9.6.5 SWOT analysis
9.7 3Dynamics Systems
- 9.7.1 Business overview
- 9.7.2 Financial data
- 9.7.3 Product landscape
- 9.7.4 Strategic outlook
- 9.7.5 SWOT analysis
9.8 Envision TEC
- 9.8.1 Business overview
- 9.8.2 Financial data
- 9.8.3 Product landscape
- 9.8.4 Strategic outlook
- 9.8.5 SWOT analysis
9.9 Luxexel
- 9.9.1 Business overview
- 9.9.2 Financial data
- 9.9.3 Product landscape
- 9.9.4 Strategic outlook
- 9.9.5 SWOT analysis
9.10 Materialise NV
- 9.10.1 Business overview
- 9.10.2 Financial data
- 9.10.3 Product landscape
- 9.10.4 Strategic outlook
- 9.10.5 SWOT analysis
9.11 Nano3D Biosciences
- 9.11.1 Business overview
- 9.11.2 Financial data
- 9.11.3 Product landscape
- 9.11.4 Strategic outlook
- 9.11.5 SWOT analysis
9.12 Oceanz
- 9.12.1 Business overview
- 9.12.2 Financial data
- 9.12.3 Product landscape
- 9.12.4 Strategic outlook
- 9.12.5 SWOT analysis
9.13 Organovo Holdings, Inc
- 9.13.1 Business overview
- 9.13.2 Financial data
- 9.13.3 Product landscape
- 9.13.4 Strategic outlook
- 9.13.5 SWOT analysis
9.14 regenHU
- 9.14.1 Business overview
- 9.14.2 Financial data
- 9.14.3 Product landscape
- 9.14.4 Strategic outlook
- 9.14.5 SWOT analysis
9.15 Renishaw
- 9.15.1 Business overview
- 9.15.2 Financial data
- 9.15.3 Product landscape
- 9.15.4 Strategic outlook
- 9.15.5 SWOT analysis
9.16 Solidscape
- 9.16.1 Business overview
- 9.16.2 Financial data
- 9.16.3 Product landscape
- 9.16.4 Strategic outlook
- 9.16.5 SWOT analysis
9.17 Stratasys Ltd
- 9.17.1 Business overview
- 9.17.2 Financial data
- 9.17.3 Product landscape
- 9.17.4 Strategic outlook
- 9.17.5 SWOT analysis
9.18 Tevido BioDevices
- 9.18.1 Business overview
- 9.18.2 Financial data
- 9.18.3 Product landscape
- 9.18.4 Strategic outlook
- 9.18.5 SWOT analysis
9.19 3D Bioprinting Solutions
- 9.19.1 Business overview
- 9.19.2 Financial data
- 9.19.3 Product landscape
- 9.19.4 Strategic outlook
- 9.19.5 SWOT analysis
9.20 3D Biotek
- 9.20.1 Business overview
- 9.20.2 Financial data
- 9.20.3 Product landscape
- 9.20.4 Strategic outlook
- 9.20.5 SWOT analysis
9.21 3D Systems Inc.
- 9.21.1 Business overview
- 9.21.2 Financial data
- 9.21.3 Product landscape
- 9.21.4 Strategic outlook
- 9.21.5 SWOT analysis